Dr. Thomas Lingner

Chief Technology Officer

Dr. Thomas Lingner joined BellaSeno as Chief Technology Officer in March 2024. In addition to his role at BellaSeno, he is Managing Director and CSO of Genevention GmbH, a bioinformatics / software company he co-founded in 2017. Prior to this, he was Principal Bioinformatician, Microarray and Deep-Sequencing Core Facility, at the University Medical Center Göttingen. From 2008 to 2014, Thomas Lingner worked as a Post-Doctoral Researcher at the University of Göttingen, CRG Barcelona, Spain and the University of Stavanger, Norway. He holds a PhD in Bioinformatics from the University of Göttingen and a Diploma in Computer Science from the University of Bielefeld, Germany.